Ideas

November 5, 2017

Published by admin_auro at November 5, 2017

Categories

Antiviral therapy against Neuroinvasive West Nile virus: Nafamostat Mesilate (NM) increases the expression of RIPK3, promotes chemokines production, inhibits neuroinflammation, and restricts neuroinvasive West Nile virus production and pathogenesis in neurons via up regulation of its target gene, 11/November/2017, 10.41 pm

Introduction: What they say A study from the Department of Immunology, University of Washington, Seattle, WA 98109, USA; Center for Innate Immunity and Immune Disease, University of […]

November 4, 2017

Published by admin_auro at November 4, 2017

Categories

Natural product-based therapy for Deafness: A therapeutic mix encompassing Fenofibrate, Cholecalciferol, and DIM (FECAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration, improves hearing loss via up regulation of its target genes, 05/November/2017, 12.08 am

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: A therapeutic mix encompassing Fenofibrate, Cholecalciferol, and DIM (FECAD) increases the […]

November 4, 2017

Published by admin_auro at November 4, 2017

Categories

Ideas
NAFLD

Natural product therapy for Non-alcoholic fatty liver disease (NAFLD): Linalool, isolated from Coriander, Palmarosa, Sweet orange, and lavender, promotes degradation of HMGCR, decreases the levels of triglycerides, free cholesterol, and total cholesterol and prevents the progression of Non-alcoholic fatty liver disease (NAFLD via down regulation of its target gene, 4/November/2017, 11.58 pm

Significance of the study: Given that: (1) 15-30% of Western populations suffer from Non-alcoholic fatty liver disease (NAFLD), while 6-25% of Asian populations suffer from it; (2) 75 to […]

November 4, 2017

Published by admin_auro at November 4, 2017

Categories

Natural product-based combinatorial therapy for ageing-associated diseases and Lifespan extension: A therapeutic mix encompassing Glycyrrhetinic acid, Ginsenoside and 4-Bromoflavone (GGB) increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 4/November/2017, 11.51 pm

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]